化倾向 (T50) 预测移植接受者功能快速下降
Nathalie Hammer1, David Legouis2, Andreas Pasch3,4
1Service of Nephrology, Inselspital, 3010 Bern, Switzerland.
Journal of clinical medicine
|June 28, 2023
概括
血清化倾向 (T50) 预测移植接受者的功能快速下降. 在这项研究中,其他标志物如FGF23和Klotho与恶化的结局无关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 生物标志物发现发现
背景情况:
- 传统的标记物,如血清肌素,蛋白尿和间歇性纤维化,可以预测的预后.
- 慢性病患者脏不良结果的新兴决定因素包括FGF23,FEP/FGF23比率,TRP,T50和Klotho.
- 识别新的生物标志物对于预测移植受体的结果至关重要.
研究的目的:
- 分析FGF23,FEP/FGF23,TRP,T50和Klotho对移植接受者的功能迅速下降的预测效用.
- 为了评估这些酸标记物与移植后功能丧失的关联.
主要方法:
- 一项回顾性研究,在4年内对103名移植患者进行了前性随访.
- 对快速功能下降的预测值的分析,定义为EGFR>30%的下降.
- 评估与eGFR变化相关的FGF23,FEP/FGF23,TRP,T50和Klotho水平.
主要成果:
- 在4年的随访期间,23名患者的功能迅速下降.
- 没有发现FGF23,FEP/FGF23,TRP或Klotho土与快速EGFR下降的风险增加之间存在显著的关联.
- 血清化倾向的下三位数 (T50) 与>30%的eGFR下降显著相关 (HR 3.86,p=0.048),在多变量分析中仍然显著.
结论:
- 血清化倾向 (T50) 是移植受体功能快速下降的强大,独立的预测因子.
- T50作为一个有价值的生物标志物,用于监测移植后的功能损失.
- 在这个队列中,FGF23,FEP/FGF23,TRP和Klotho没有显示出快速功能下降的预测价值.
相关概念视频
01:28Kidney Transplant I: Introduction
29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
01:11Renal Failure: Dose Adjustments
127
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
127
01:17Factors Affecting Renal Clearance: Renal Impairment
123
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
123
01:28Renal Drug Excretion: Tubular Secretion
231
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
231
01:25Chronic Kidney Disease I: Introduction
43
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
43
01:16Kidney Transplant III: Nursing Management
41
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
41